Trial Profile
A multicentre, randomized, intraindividual comparative pharmacokinetic trial to evaluate the bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary) ; Brimonidine
- Indications Erythema
- Focus Pharmacokinetics
- 02 Dec 2015 New trial record